Roche Holding AG (RHHBY)
54.15
-0.48
(-0.88%)
USD |
OTCM |
Sep 18, 16:00
Roche Total Return Level : 105.91 for Sept. 18, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 18, 2026 | 105.91 |
| September 17, 2026 | 106.85 |
| September 16, 2026 | 107.87 |
| September 15, 2026 | 107.46 |
| September 14, 2026 | 107.18 |
| September 11, 2026 | 103.17 |
| September 10, 2026 | 104.03 |
| September 09, 2026 | 104.40 |
| September 08, 2026 | 105.75 |
| September 04, 2026 | 107.50 |
| September 03, 2026 | 108.00 |
| September 02, 2026 | 105.28 |
| September 01, 2026 | 103.84 |
| August 31, 2026 | 105.03 |
| August 28, 2026 | 107.94 |
| August 27, 2026 | 110.29 |
| August 26, 2026 | 111.27 |
| August 25, 2026 | 114.36 |
| August 24, 2026 | 112.40 |
| August 21, 2026 | 113.63 |
| August 20, 2026 | 111.97 |
| August 19, 2026 | 113.83 |
| August 18, 2026 | 108.60 |
| August 17, 2026 | 106.81 |
| August 14, 2026 | 106.63 |
| Date | Value |
|---|---|
| August 13, 2026 | 108.53 |
| August 12, 2026 | 110.52 |
| August 11, 2026 | 110.74 |
| August 10, 2026 | 112.32 |
| August 07, 2026 | 111.99 |
| August 06, 2026 | 109.86 |
| August 05, 2026 | 110.33 |
| August 04, 2026 | 108.39 |
| August 03, 2026 | 107.73 |
| July 31, 2026 | 106.93 |
| July 30, 2026 | 108.10 |
| July 29, 2026 | 107.51 |
| July 28, 2026 | 110.54 |
| July 27, 2026 | 107.12 |
| July 24, 2026 | 106.98 |
| July 23, 2026 | 105.46 |
| July 22, 2026 | 101.12 |
| July 21, 2026 | 100.02 |
| July 20, 2026 | 99.75 |
| July 17, 2026 | 100.92 |
| July 16, 2026 | 100.63 |
| July 15, 2026 | 100.10 |
| July 14, 2026 | 98.11 |
| July 13, 2026 | 98.77 |
| July 10, 2026 | 101.51 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Novartis AG | 314.18 |
| AstraZeneca PLC | 419.21 |
| Eli Lilly & Co. | 3046.28 |
| Merck & Co., Inc. | 454.18 |
| Pfizer Inc. | 92.52 |